Methoxetamine: Difference between revisions
>Unity enlarged generic structure diagram |
>Cyrilio m The original link was dead ( http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php ) |
||
Line 7: | Line 7: | ||
'''3'-MeO-2-Oxo-PCE''' (commonly known as '''Methoxetamine''', '''MXE''', and also as '''Mexxy''') is a synthetic [[psychoactive class::dissociative]] of the [[Chemical class::arylcyclohexylamine]] class. | '''3'-MeO-2-Oxo-PCE''' (commonly known as '''Methoxetamine''', '''MXE''', and also as '''Mexxy''') is a synthetic [[psychoactive class::dissociative]] of the [[Chemical class::arylcyclohexylamine]] class. | ||
This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other ailments.<ref>Interview with a ketamine chemist | | This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other ailments.<ref>Interview with a ketamine chemist | https://www.vice.com/en_us/article/interview-with-ketamine-chemist-704-v18n2</ref> It is a chemical derivative of [[ketamine]] that also contains structural features of [[phencyclidine]] (PCP) and [[3-MeO-PCP]]. | ||
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref> | <ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref> | ||